Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.
- Revenue
- +1.92%
- EPS
- +143.9%
- Free cash flow
- +8.26%
Quarter to September 2026, against a year earlier
Follow ALGN
Alert me
Align Technology, Inc. 10-Q filed Nov 5, 2025
What changed
Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Aug 6, 2025: 12 added · 10 removed · 39 modified; 28 with only figures updated; 3 moved without change
-
Modified · Forward-Looking Statements
In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include, among other things, our expectations and intentions regarding our strategic objectives
, business strategy and growth drivers, and the means to achieve them,; our beliefs and expectations regarding macroeconomic conditions, including fluctuations in currency exchange rates, higher interest rates, market volatility, threats or actual imposition of tariffs, customs duties and fees by nations and retaliatory actions, inflation, threats of or actual economic slowdowns or recessions, or trade wars and geopolitical tensions,; our expectations and beliefs regarding customer and consumer confidence, purchasing behavior and demand for dental services and changes in consumer spending habits; our expectations regarding implemented or proposed tariffs and retaliatory actions or other trade restrictions or measures taken by the United States and other countries that have or could impact our products and product sales,; our expectations regarding product mix, product launches, product pilots and product adoption,; our expectations regarding competition and our ability to compete in our target markets,; our expectations regarding the sales growth of ourintraoral scannersclear aligners,clear alignersintraoral scanners and other products,; our expectations regarding the impact of the military conflicts in Ukraine and the Middle Eastand Ukraine, including military actions in Israel and increased geopolitical tensions involving Taiwan and the South China Seaand, on our employees, operations and assets, particularly in Israel and Russia,; our ability to implement and realize the anticipated benefits currently expected fromactions to streamline operations and reallocate resources to better align our long-term growth with our profitability objectives,our restructuring plan initiated in the third quarter of 2025, as well as the anticipated expenses we will incur pursuant to the plan; our marketing and efforts to build our brand awareness,; our estimates regarding the size and opportunities oftheour target marketswe are targetingalong with our expectations for growth in those markets and potential collaboration opportunities,; our beliefs regarding the general impact of technological innovationin general,andinon our particular solutions and productsin particular, on target markets and patient care,; our beliefs regarding digital dentistry and its potential to impact our business,and transform dentistry; our intentions regardingexpandingexpansion of our business, including its impactand any impacts on our operational flexibility and responsiveness to customer demand,; our expectations regarding our tax positions and the judgments we make related to our tax obligations,; our beliefs regarding the importance of our manufacturing operations on our success,; our beliefs regarding the need for and benefits of our technological development on Invisalign treatment, the areas of development in which we focus our efforts, and the advantages of our intellectual property portfolio,; ourbeliefs regarding our business strategy and growth drivers, ourexpectations regarding the utilization rates for our products, including the impact of marketing on those rates and causes for periodic fluctuations of the rates,; our expectations regarding the existence and impact of seasonality,; our expectations regarding theproductivity impact sales representatives will have on our sales and the impact of specialization of those representatives in sales channels, our expectations regarding thecontinued expansion of our international markets and their growth,; our expectations regarding impacts or staying in compliance with laws and regulations currently applicable to, or which may become applicable to, our business both in the United States and internationally,; our beliefs regarding our culture and commitment and its impact on our financial and operational performance and its importance to our future success,; our expectations for future investments in and benefits from sales and marketing activities,; our preparedness and our customers’ preparedness to react to changing circumstances and demand,; our expectations for our expenses and capital obligations and expenditures in particular,; our intentions to control spending and for investments, our intentions regarding the investment of and ability to repatriate foreign earnings,; our belief regarding the sufficiency of our cash and investment balances and borrowing capacity,; our judgments regarding the estimates used in our revenue recognition and assessment of goodwill and intangible assets,; our predicted level of operating expenses and gross margins and other factors beyond our control, as well as other statements regarding our future operations, financial condition and prospects and business strategies. These statements may contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” or other words indicating future results. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in particular, the risks discussed below in Part II, Item 1A “Risk Factors.” We undertake no obligation to revise or update these forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.